<VariationArchive RecordType="classified" VariationID="100785" VariationName="NM_006030.4(CACNA2D2):c.1295del (p.Asn432fs)" VariationType="Deletion" Accession="VCV000100785" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2019-07-27" MostRecentSubmission="2019-07-27">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="106650" VariationID="100785">
      <GeneList>
        <Gene Symbol="CACNA2D2" FullName="calcium voltage-gated channel auxiliary subunit alpha2delta 2" GeneID="9254" HGNC_ID="HGNC:1400" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="50362613" stop="50504244" display_start="50362613" display_stop="50504244" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="50400229" stop="50540891" display_start="50400229" display_stop="50540891" Strand="-" />
          </Location>
          <OMIM>607082</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006030.4(CACNA2D2):c.1295del (p.Asn432fs)</Name>
      <CanonicalSPDI>NC_000003.12:50378958:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="50378959" stop="50378959" display_start="50378959" display_stop="50378959" variantLength="1" positionVCF="50378958" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="50416390" stop="50416390" display_start="50416390" display_stop="50416390" variantLength="1" positionVCF="50416389" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>N363fs</ProteinChange>
      <ProteinChange>N432fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.50416391del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.50416391del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.50378960del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.50378960del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_034070.1" sequenceAccession="NG_034070" sequenceVersion="1" change="g.130286del">
            <Expression>NG_034070.1:g.130286del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001005505.3" sequenceAccession="NM_001005505" sequenceVersion="3" change="c.1295del">
            <Expression>NM_001005505.3:c.1295del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001005505.1" sequenceAccession="NP_001005505" sequenceVersion="1" change="p.Asn432fs">
            <Expression>NP_001005505.1:p.Asn432fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001174051.3" sequenceAccession="NM_001174051" sequenceVersion="3" change="c.1295del">
            <Expression>NM_001174051.3:c.1295del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001167522.1" sequenceAccession="NP_001167522" sequenceVersion="1" change="p.Asn432fs">
            <Expression>NP_001167522.1:p.Asn432fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001291101.1" sequenceAccession="NM_001291101" sequenceVersion="1" change="c.1088del">
            <Expression>NM_001291101.1:c.1088del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001278030.1" sequenceAccession="NP_001278030" sequenceVersion="1" change="p.Asn363fs">
            <Expression>NP_001278030.1:p.Asn363fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006030.4" sequenceAccession="NM_006030" sequenceVersion="4" change="c.1295del" MANESelect="true">
            <Expression>NM_006030.4:c.1295del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006021.2" sequenceAccession="NP_006021" sequenceVersion="2" change="p.Asn432fs">
            <Expression>NP_006021.2:p.Asn432fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA228967" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607082.0002" DB="OMIM" />
        <XRef Type="rs" ID="587777165" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006030.4(CACNA2D2):c.1295del (p.Asn432fs) AND Cerebellar atrophy with seizures and variable developmental delay" Accession="RCV000087148" Version="4">
        <ClassifiedConditionList TraitSetID="48128">
          <ClassifiedCondition DB="MedGen" ID="C5193132">Cerebellar atrophy with seizures and variable developmental delay</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-07-27" MostRecentSubmission="2019-07-27">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24358150</ID>
        </Citation>
        <DescriptionHistory Dated="2019-07-25">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="48128" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="42249" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cerebellar atrophy with seizures and variable developmental delay</ElementValue>
                <XRef ID="MONDO:0032788" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CASVDD</ElementValue>
                <XRef Type="MIM" ID="618501" DB="OMIM" />
              </Symbol>
              <XRef ID="C5193132" DB="MedGen" />
              <XRef ID="MONDO:0032788" DB="MONDO" />
              <XRef Type="MIM" ID="618501" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="211274" SubmissionDate="2019-07-22" DateLastUpdated="2019-07-27" DateCreated="2014-03-02">
        <ClinVarSubmissionID localKey="607082.0002_CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY" title="CACNA2D2, 1-BP DEL, 1295A_CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY" />
        <ClinVarAccession Accession="SCV000120010" DateUpdated="2019-07-27" DateCreated="2014-03-02" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 9-year-old boy, born of consanguineous Italian parents, with cerebellar atrophy with seizures and variable developmental delay (CASVDD; 618501) manifest as epileptic encephalopathy, Pippucci et al. (2013) identified a homozygous 1-bp deletion (c.1295delA, chr3.50,416,390, GRCh37) in the CACNA2D2 gene, resulting in a frameshift and premature termination (Asn432fs) at the level of the alpha-2 segment. The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. The mutant protein was predicted to lack anchoring to the membrane and thus would be unable to assemble with the pore-forming unit. Patient cells showed almost absent CACNA2D2 protein levels (less than 3% of controls). Genetic analysis also identified a homozygous missense G2136D variant in the CELSR3 gene (604264.0002) that segregated with the disorder in the family. However, calculation of statistical significance of the CELSR3 variant suggested that it was likely an incidental finding. Pippucci et al. (2013) noted the phenotypic similarities to the 'ducky' mouse (see ANIMAL MODEL).</Attribute>
              <Citation>
                <ID Source="PubMed">24358150</ID>
              </Citation>
              <XRef DB="OMIM" ID="618501" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA2D2" />
          </GeneList>
          <Name>CACNA2D2, 1-BP DEL, 1295A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1295A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607082.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="211274" TraitType="Disease" MappingType="Name" MappingValue="CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY" MappingRef="Preferred">
        <MedGen CUI="C5193132" Name="Cerebellar atrophy with seizures and variable developmental delay" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

